VIBE
Consumer functional music app
Mobile app offering functional music for focus, energy, recovery and sleep; available on the App Store.
Learn more SourceLUCID
AIDigital Health & HealthTechToronto, ON
Toronto company selling VIBE and Resonance Rx, AI-curated therapeutic music apps that use reinforcement learning and facial-expression-based "Emotion AI" to target anxiety, stress and dementia-related agitation.
Canadian innovation builds a brighter tomorrow.
About
Company site: thelucidproject.caToronto company selling VIBE and Resonance Rx, AI-curated therapeutic music apps that use reinforcement learning and facial-expression-based "Emotion AI" to target anxiety, stress and dementia-related agitation.
Federal corporation 1049153-5 (Lucid, Inc.), status Active, registered office in Toronto, Ontario since incorporation on 2017-11-10. ised-isde.canada.ca
Closed a $3.14M CAD all-equity seed round in 2022 led by Amplify Capital, with Relentless Venture Fund, MEDTEQ+, the Ontario Centre of Innovation's Market Readiness Co-Investment Fund and others. betakit.com
Resonance Rx, its digital therapeutic for older adults, is described on its own site as "FDA Authorized" and "Medicare Reimbursable" in the U.S. resonance-rx.com
Partnered with Mila (Montreal deep learning institute) in 2022 on three ML systems (AMRS, BioMIR, Absorption) for personalizing therapeutic music. mila.quebec
A January 2026 trial with Toronto Metropolitan University, published in PLOS Mental Health, found 24 minutes of LUCID's music with auditory beat stimulation reduced anxiety versus pink noise. torontomu.ca
Products & Services
Company site: thelucidproject.caProducts LUCID publishes on its own site. Each card links to the page it was taken from.
Resonance Rx
Digital therapeutic for older adults
AI-personalized music combined with CBT podcasts and guided meditation for anxiety, depression and agitation in older adults, using facial-expression-based music selection; described as FDA Authorized and Medicare Reimbursable.
Learn moreFunding & Investors
Announced rounds only, newest first. Undisclosed amounts are shown as undisclosed.
Seed
Aug 12, 2022
C$3.1Mbetakit.comInvestors: Amplify Capital, Relentless Venture Fund, MEDTEQ+, Ontario Centre of Innovation's Market Readiness Co-Investment Fund, Reverb Ventures, Hunter Family Foundation, Leva Capital
Total disclosed: C$3.1MLatest: Seed · Aug 12, 2022
Partnerships
Publicly announced partnerships.
Mila
Partnered in 2022 to develop three machine-learning systems (AMRS, BioMIR, Absorption) for optimal music selection and personalized therapeutic response.
JT
Developing a prescription digital therapeutic with Japanese pharmaceutical company JT to reduce agitation and anxiety in dementia and Alzheimer's care, per BetaKit.
Government & Grants
Government support actually received. Unpublished amounts are left out.
Industrial Research Assistance Program, National Research Council Canada
Industrial Research Assistance Program, National Research Council Canada
Industrial Research Assistance Program, National Research Council Canada
Industrial Research Assistance Program – AI Assist, National Research Council Canada
Canadian International Innovation Program, National Research Council Canada
Industrial Research Assistance Program – Contributions to Firms, National Research Council Canada — contribution
Recent News
- Jan 21, 2026Research
New clinical trial by TMU and LUCID find new method to significantly reduce anxiety
A randomized trial of 144 adults found 24 minutes of music with auditory beat stimulation significantly reduced cognitive and somatic anxiety versus a pink-noise control, published in PLOS Mental Health.
- Aug 12, 2022Funding
LUCID closes $3 million to turn music into medicine for Alzheimer's patients
LUCID closed a $3.14M CAD all-equity seed round led by Amplify Capital to continue developing its digital therapeutics, including a partnership with Japanese pharmaceutical company JT.
- Jun 28, 2022Partnership
LUCID Announces Partnership with Mila to Advance Machine Learning in Therapeutic Music
LUCID and Mila partnered to build three ML systems (AMRS, BioMIR, Absorption) to personalize therapeutic music selection and predict psychological response.
People
Sourced from the company's own pages or announcements.
Zach McMahon
Co-Founder & Chief Executive Officer
Aaron Labbé
Co-Founder & Chief Technology Officer
Zoë Thomson
Co-Founder & Chief Innovation Officer
Technology Focus
Company site: thelucidproject.caTerms the company uses about its own work.
Emotion AIReinforcement learningDigital therapeuticsPersonalized music generation
Similar Companies
Other companies in AI.
